| Modulation of beta-catenin levels or disruption of its cell adhesion role is correlated with aggressive tumorigenesis in basal ErbB2-driven mammary tumors with preexisting beta-catenin activation. Our data also emphasize the tumor suppressor role of beta-catenin, similar to other adherens junction proteins, in maintaining junctional integrity during tumor progression. | None |
| Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles. | liver, |
| Predominant mutation of codon 41 of the beta-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol. | colorectal, |
| Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. | colorectal, |
| [The Rudolf Virchow Prize 2001. The role of the oncoprotein beta-catenin ni the progression of colorectal cancers]. | colorectal, |
| Stimulation of Cdx1 by oncogenic beta-catenin/Tcf4 in colon cancer cells; opposite effect of the CDX2 homeoprotein. | colorectal, |
| beta-catenin plays an important role in oncogenesis through the crossregulation of NF-kappa B in breast and colonic neoplasms | colorectal,neoplasm,breast, |
| PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma. | liver, |
| [Activating a beta-catenin signal in the liver is oncogenic]. | liver, |
| G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway. | colorectal, |
| Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. | liver, |
| Oncogenic beta-catenin signaling networks in colorectal cancer. | colorectal, |
| Up-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. | lymphoma, |
| Modulation of oncogenic transcription and alternative splicing by beta-catenin and an RNA aptamer in colon cancer cells. | colorectal, |
| Adjuvant immunochemotherapy with protein-bound polysaccharide K for colon cancer in relation to oncogenic beta-catenin activation. | colorectal, |
| KIT regulates tyrosine phosphorylation and nuclear localization of beta-catenin in mast cell leukemia. | leukemia, |
| Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. | lung, |
| The stabilization of beta-catenin, via association with a mutated TRbeta, represents a novel activating mechanism of the oncogenic protein beta-catenin that could contribute to thyroid carcinogenesis in TRbeta(PV/PV) mice. | thyroid, |
| Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. | pancreatic, |
| TCF/beta-catenin plays an important role in HCCR-1 oncogene expression. | liver, |